Slide 1: Optomed Q3 2025
Optomed Q3 2025 6th November 2025 Juho Himberg, CEO Sakari Knuutti, CFO
Slide 2: Highlights Q3
Highlights Q3 1. 2. 3. 47.0 % currency- Devices segment The US market adjusted revenue continued its strong continues to growth momentum with perform very well currency adjusted growth of 202.5%
Slide 3: Q3-2025 Key Figures
Q3-2025 Key Figures WE CONTINUED THE GOOD TREND SINCE Q4-2024 WITH 47.0 % CURRENCY-ADJUSTED GROWTH Q3/2025 Q3/2024 Change Revenue 4,417 3,109 42.1% Gross profit 2,728 1,692 61.2% Gross margin 61.8% 54.4% +74pps EBITDA -536 -814 34.2% EBITDA margin -12.1% -26.2% +141pps Net profit / loss -1,530 -1,57
Slide 4: Q1-Q3/2025 Key Figures
Q1-Q3/2025 Key Figures CURRENCY-ADJUSTED REVENUE GROWTH WAS 26.7 PERCENT DURING Q1-Q3 Q1-Q3/2025 Q1-Q3/2024 Change Revenue 12,284 9,941 23.6% Gross profit 7,918 6,355 24.6% Gross margin 64.5% 63.9% +6pps EBITDA -2,193 -2,647 17.1% EBITDA margin -17.9% -26.6% +87pps Net profit / loss -4,755 -4,460 -6
Slide 5: Segment highlights
Segment highlights OPT@MED
Slide 6: Devices Segment Q3-2025
Devices Segment Q3-2025 ANOTHER SOLID QUARTER FOR DEVICES WITH 202.5 % GROWTH ON CURRENCY ADJUSTED BASIS Q3/2025 Q3/2024 Change Revenue growth continued 1. very strong driven by the US Revenue 2,305 813 183.6% Broad-based momentum Gross profit 1,247 91 1277.0% 2. across markets Gross margin 54.1% 11
Slide 7: Software Segment Q3-2025
Software Segment Q3-2025 SLIGHT DECLINE IN THE SOFTWARE SEGMENT Q3/2025 Q3/2024 Change Healthcare business 1. remained stable Revenue 2,113 2,297 -8.0% Non-healthcare consulting Gross profit 1,481 1,602 -7.5% 2. revenue continued its decline Gross margin 70.1% 69.7% +4pps General IT consulting marke
Slide 8: Strategic Progress
Strategic Progress SLIGHT DECLINE IN THE SOFTWARE SEGMENT Optomed Lumo entered the market as 1. planned Aurora AEYE continued to develop 2. positively The collaboration with a global top-10 3. pharma company progressed well during the quarter China: joint venture continues to 4. develop as planned
Slide 9: Cash Flow Q3-2025
Cash Flow Q3-2025 CASH POSITION AT EUR 5.3 MILLION Q3 2025 Q3 2024 Loss for the financial year -1,530 -1,577 • Improved cash flow from Cash flows before change -725 -1,115 in net working capital operating activities Change in net working capital -297 -324 • The comparison period was Cash flows befor
Slide 10: Outlook 2025
Outlook 2025 OPTOMED EXPECTS ITS FULL YEAR 2025 REVENUE TO GROW STRONGLY COMPARED TO 2024 Key items supporting our growth: Areas of uncertainty and pressure on growth: • Increased adoption of AI-powered screening • Challenges to accurately forecast the timing and solutions, particularly in the U.S.
Slide 11: Summary
Summary • Very strong performance in the Devices segment and especially in the US • Aurora AEYE continues to scale steadily in both adoption and usage • Strategic projects continue as planned • Optomed expects its full year 2025 revenue to grow strongly compared to 2024
Slide 12: Appendix
Appendix OPT@MED
Slide 13: Devices Segment Q1-Q3/2025
Devices Segment Q1-Q3/2025 Q1-Q3/2025 Q1-Q3/2024 Change 1. Revenue grew 88.8 % Revenue 5,240 2,776 88.8% Gross profit 2,951 1,302 126.7% 2. EBITDA increased 79.5% Gross margin 56.3% 46.9% +94pps EBITDA -319 -1,558 79.5% EBITDA margin -6.1% -56.1% +500pps
Slide 14: Software Segment Q1-Q3/2025
Software Segment Q1-Q3/2025 Q1-Q3/2025 Q1-Q3/2024 Change 1. Revenue decreased1.7% Revenue 7,044 7,165 -1.7% Gross profit 4,967 5,044 -1.5% 2. EBITDA decreased 14.4% Gross margin 70.5% 70.4% +1pps EBITDA 1,257 1,468 -14.4% EBITDA margin 17.8% 20.5% -27pps
Slide 15: Cash Flow Q1-Q3/2025
Cash Flow Q1-Q3/2025 Q1-Q3 2025 Q1-Q3 2024 • Cash flows before change Loss for the financial year -4,755 -4,460 in net working capital Cash flows before change EUR -2.0 million in net working capital -2,029 -2,415 • Cash position at EUR 5.3 Change in net working capital -305 471 million Cash flows b
Slide 16: Balance Sheet
Balance Sheet 30 September 2025 30 September 2024 • Equity ratio of 74.4 (76.5) ASSETS Goodwill 4,256 4,256 percent Development costs 8,741 8,212 Other intangible assets 1,154 1,494 • Total borrowings of EUR Total intangible assets 14,152 13,962 1.6 (2.6) million Total tangible assets 790 592 Total